Net direct expenditure on patented medicines by public drug plans in 10 Canadian provinces in 2023
Brett Skinner, PhD | CEO CHPI, Editor CHPJ | ABSTRACT – Canada’s federal, provincial, and
Research Abstract
Documenting Long-Acting Reversible Contraceptive (LARC) Coverage Across Canada
Haylie Simmons, BSc; Nichole Austin, PhD; Daniel Dutton, PhD | Dalhousie University | ABSTRACT –
Access to new drugs on public formularies in 10 Canadian provinces 2019 to 2024
Brett Skinner, PhD | CEO CHPI, Editor CHPJ | ABSTRACT –
The impact of pharmaceutical innovation on mortality and hospital utilization in Canada, 2000–2022
Frank R Lichtenberg, PhD | Columbia University, National Bureau of Economic Research | ABSTRACT –